Whipplewood Advisors, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 2052510 LITTLETON, CO

Position in GILD

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$2,905

-$37,233 QoQ

Shares Held

-92.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#2,228

of 2,266 holders

Holding Since

Dec 2024

6 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Whipplewood Advisors, LLC holds $222,965 across 12 Drug Manufacturers - General names. GILD ranks #11 (1.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NVS	Novartis AG	278	$43,568
2	JNJ	Johnson & Johnson	147	$37,333
3	AZN	Astrazeneca PLC	149	$28,253
4	LLY	ELI LILLY & Co	22	$26,387
5	ABBV	AbbVie Inc.	101	$25,415
6	MRK	Merck & Co., Inc.	169	$21,716
7	AMGN	Amgen Inc	49	$17,743
8	GSK	GSK plc	130	$6,814

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,905	23	-92.0%	Shares	Sole	2026-07-27
2026-03-31	$40,138	288	+4700.0%	Shares	Sole	2026-04-30
2025-12-31	$736	6	-98.4%	Shares	Sole	2026-02-17
2025-06-30	$42,684	385	0.0%	Shares	Other	2025-07-31
2025-03-31	$1,568	385	+2.4%	Shares	Sole	2025-04-10
2024-12-31	$34,730	376	—	Shares	Sole	2025-02-05
No filing history on record for this holder in this stock.